The president underwent a comprehensive medical exam after experiencing swelling in his lower legs in recent weeks.
SPECIAL COVERAGE
-
See the latest news and information about COVID-19 and its impact on the Charlotte region, the Carolinas and beyond.
-
Americans spend more on medical care than those in other wealthy countries, but we’re a lot sicker. The Price We Pay will explore the reasons for that and possible solutions to our health care crisis.
-
Summertime is peak tick season, and it hits harder in some North Carolina communities than others. Public health agency AppHealthCare says people in Alleghany, Ashe and Watauga are at higher risk for tick-borne diseases than those in other North Carolina counties.
-
It's called parametric insurance, it offers protection for climate-related wage losses and it's gaining ground in India.
-
Low-income and marginalized communities often stand to benefit the most from climate solutions because these communities bear the most direct costs of fossil fuel pollution.
-
Research led by the National Cancer Institute determined those those that used the chemical, frequently sold under the brand name Sevin, have a higher risk of stomach, esophageal, tongue and prostate cancers.
-
Threats to $140 million in funds for public health departments battling fentanyl overdoses comes as some experts see the addiction safety net unraveling.
-
Retired service members donated genetic material to a DNA database to help answer health questions for all Americans. The Trump administration is dragging its heels on agreements to analyze the data.
-
Doctors are writing "social prescriptions" to get people engaged with nature, art, movement and volunteering. Research shows it can help with mental health, chronic disease and dementia.
-
Prison officials plan to install air conditioning for all prison beds by 2026 as rising temperatures pose growing health risks for incarcerated people.
-
The UNAIDS annual report warns that Trump-era HIV funding cuts could lead to 6 million more infections and 4 million deaths by 2029 — as low-income countries struggle to fill the gap.
-
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.
-
The parents of a transgender child say Atrium Health told them it will end gender-affirming care for youth by the end of the month. However, there has been no clarification from the system.
-
The symptoms can include nerve pain, emotional numbness and sexual dysfunction and can last for years after stopping the drugs. Patients are pushing for recognition and more research.